Atrial Fibrillation and Other Clinical Manifestations of Altered TBX5 Dosage in Typical Holt-Oram Syndrome.
McDermott
Deborah A
DA
Hatcher
Cathy J
CJ
Basson
Craig T
CT
D000015:Abnormalities, Multiple; D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000818:Animals; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000235:genetics*; D001667:Binding, Competitive; D002478:Cells, Cultured; D002648:Child; D004247:DNA / Q000378:metabolism / Q000494:pharmacology; D004562:Electrocardiography; D005260:Female; D005786:Gene Expression Regulation; D018014:Gene Transfer Techniques; D008040:Genetic Linkage; D005820:Genetic Testing; D000072576:Homeobox Protein Nkx-2.5; D018398:Homeodomain Proteins / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D021381:Protein Transport / Q000235:genetics; D051381:Rats; D013577:Syndrome; D020825:T-Box Domain Proteins / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism; D014157:Transcription Factors; D020798:Two-Hybrid System Techniques
D000072576:Homeobox Protein Nkx-2.5; D018398:Homeodomain Proteins; C095552:NKX2-5 protein, human; D020825:T-Box Domain Proteins; C103172:T-box transcription factor 5; D014157:Transcription Factors; D004247:DNA